Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mina Shahnazari"'
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-18 (2023)
Abstract The HAND2-AS1 (HAND2 Antisense RNA 1) Long noncoding RNA (lncRNA) has emerged as a participant in the initiation of various cancer types, underscoring its pivotal involvement in both oncological processes and immune responses. To gain deeper
Externí odkaz:
https://doaj.org/article/0ff45a87fe3a462488cd0b35b9031499
Autor:
Mina Shahnazari, Mohammad Mahdi Majzoobi, Fariba Keramat, Younes Mohammadi, Rezvan Najafi, Hamid Reza Ghasemi Basir, Fatemeh Bahrami Banan, Akram Jalali
Publikováno v:
International Journal of Basic Science in Medicine, Vol 8, Iss 1, Pp 30-35 (2023)
Introduction: The COVID-19 crisis poses a heightened risk to vulnerable populations. Considering factors influencing deterioration, complications, and mortality, it is especially important to pay attention to these groups, including persons with hype
Externí odkaz:
https://doaj.org/article/4b6fee7e9ff0423583707ca8c6ca274d
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-19 (2023)
Abstract In recent studies, the void of evaluation and in-depth understanding of unknown clinically relevant potential molecular biomarkers involved in colorectal cancer (CRC) from the inflammatory stage of ulcerative colitis (UC) to CRC metastasis,
Externí odkaz:
https://doaj.org/article/ef7d71b7308a4303adc36ba721a37457
Publikováno v:
Future Oncology. 17:3253-3270
Immunotherapy is becoming as a major treatment modality for multiple types of solid tumors, including subsets of colorectal cancers (CRCs). The successes with immunotherapy alone has largely been achieved in patients with advanced-stage mismatch-repa
Publikováno v:
International Immunopharmacology. 88:106944
Cancer vaccines are usually derived from the patient's tumor cells or the antigens found on their surface, which may help the immune system to identify and kill these malignant cells. Current focus of many researches is designing vaccines with the ho